MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Structural and functional brain network alterations in psychogenic dystonia

    E. Sarasso, F. Agosta, A. Tomic, S. Basaia, M. Svetel, G. Mandic-Stojmenovic, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

    Objective: The aim of this study is to explore the brain structural and functional MRI abnormalities in psychogenic dystonia patients (pDYT). Background: Psychogenic movement disorders…
  • 2016 International Congress

    Cervical dystonia preceding Parkinson´s disease – Continuum – coincidence or epiphenomenon–Report of 3 cases

    J. Walch, G. Kägi (St. Gallen, Switzerland)

    Objective: To report 3 cases with cervical dystonia and dystonic hand tremor who developed Parkinson´s disease (PD) years to decades later and to discuss if…
  • 2016 International Congress

    Non-motor symptoms evaluation in idiopathic cervical dystonia

    N. Novaretti, V. Tumas (Ribeirão Preto, Brazil)

    Objective: To evaluate the prevalence of non-motor symptoms associated to idiopathic cervical dystonia (CD) in a sample of patients followed in a Brazilian Movement Disorders…
  • 2016 International Congress

    Clinical outcomes of pallidal and subthalamic nucleus deep brain stimulation in isolated cranial and cranio-cervical dystonia

    N.S. Luthra, K.A. Dodenhoff, M. San Luciano, M.M. Volz, S.L. Heath, P.A. Starr, J.L. Ostrem (San Francisco, CA, USA)

    Objective: To evaluate clinical outcomes of deep brain stimulation (DBS) of globus pallidus internus (GPi) or subthalamic nucleus (STN) for isolated cranial or cranio-cervical dystonia.…
  • 2016 International Congress

    Functional characterization of the upstream start codon in the GCH1 gene

    L.C. Jones, E. Davila, L.K. Goode, P.G. Bhide, I. Armata (Tallahassee, FL, USA)

    Objective: To examine (1) the -22C > T point mutation which introduces a premature start codon upstream of the normal open reading frame (ORF) of…
  • 2016 International Congress

    Parietal hand pseudodystonia: Significant functional gains with ultrasound-guided botulinum toxin treatments

    P. Pita Lobo, C. Costa (Amadora, Portugal)

    Objective: Case report. Background: Symptomatic focal dystonia is most commonly secondary to lesions involving the basal ganglia. Previous reports have documented the occurrence of focal…
  • 2016 International Congress

    Improvement of foot progression in cervical dystonia using osteopathic manipulative medicine

    J.D. Mancini, Z. Oliff, A. LaRosa, S. Mody, R. Abu-Sbaih, A. Leder (Old Westbury, NY, USA)

    Objective: To determine if osteopathic manipulative medicine (OMM) can improve gait biomechanics in people with cervical dystonia (CD). Background: CD is a neurological disorder characterized…
  • 2016 International Congress

    Cervical dystonia associated to Wallenberg syndrome

    I. Parees, M. Romeral, D. Mayo, D. Toledo, M.E. Garcia, J. Matias-Guiu, A. Marcos, J. Porta-Etessam (Madrid, Spain)

    Objective: To describe, for the first time, a patient who developed cervical dystonia with signs and symptoms of a Wallenberg syndrome. Background: Secondary cervical dystonia…
  • 2016 International Congress

    Heterozygous TUBB4A knock-out impairs mitochondrial motility in human neuronal model of DYT4

    V. Krajka, F. Vulinovic, P. Seibler, K. Lohmann, C. Klein, A. Rakovic (Luebeck, Germany)

    Objective: To study the role of tubulin beta 4A (TUBB4A) in mitochondrial motility in isogenic induced pluripotent stem cells (iPSC)-derived neurons. Background: Heterozygous mutations in…
  • 2016 International Congress

    Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients

    C.L. Vaughan, G.T. Stebbins, C.L. Comella (Charleston, SC, USA)

    Objective: To prospectively assess the interval in weeks between injection of botulinum toxin A (BoNTA) and patient-perceived need for the next injection for treatment of…
  • « Previous Page
  • 1
  • …
  • 1898
  • 1899
  • 1900
  • 1901
  • 1902
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley